Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5

CHEN-HUA LIUJIA-HORNG KAO2022-09-092022-09-0920221936-0533https://www.scopus.com/inward/record.uri?eid=2-s2.0-85134740418&doi=10.1007%2fs12072-022-10390-z&partnerID=40&md5=d2b7c420789785130ef1b932233f7ac4https://scholars.lib.ntu.edu.tw/handle/123456789/619208[SDGs]SDG3Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5review10.1007/s12072-022-10390-z2-s2.0-85134740418